Makita Z, Nakayama H, Taneda S, Kato M, Kuroda Y, Aoki S, Misawa K, Nakagawa S
2nd Department of Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Diabetologia. 1991 Jan;34(1):40-5. doi: 10.1007/BF00404023.
A competitive radioimmunoassay for the quantitative determination of glycated haemoglobin was developed. The antiserum, obtained by immunizing guinea pigs with reduced glycated human albumin, was capable of identifying and quantitating the glucitollysine residues of glycated Hb after reduction with sodium borohydride. To simplify the sample preparation we introduced trichloroacetic acid precipitation to remove unreacted sodium borohydride instead of using dialysis or gel filtration. Using this procedure, our radioimmunoassay became relatively simple and provided satisfactory within- and between-run (1.3-2.8% and 1.9-5.4% coefficient of variation, respectively). The radioimmunoassay method was compared to the measurement of HbAlc by high performance liquid chromatography which is the most widely used method for quantitating glycated Hb. For this purpose glycated Hb was measured in normal glucose tolerance, impaired glucose tolerance, and diabetes mellitus groups based on WHO criteria. Both assays were able to discriminate between the normal and diabetic groups. In addition, while the determination of glycated Hb by the radioimmunoassay method was able to clearly discriminate between the normal and impaired glucose tolerance groups, the determination of HbAlc by the high performance liquid chromatography method failed to discriminate between these two groups. Moreover, 15 of the 20 impaired glucose tolerance patients exceeded the upper normal range (mean normal values + 2 SD) in radioimmunoassay. But all 20 patients with impaired glucose tolerance were within the upper normal range in HbAlc values. These results demonstrate that the measurement of glycated Hb by radioimmunoassay is more sensitive than the measurement of HbAlc by high performance liquid chromatography since it can discriminate between the normal and impaired glucose tolerance groups.
开发了一种用于定量测定糖化血红蛋白的竞争性放射免疫分析方法。通过用还原型糖化人白蛋白免疫豚鼠获得的抗血清,在用硼氢化钠还原后能够识别和定量糖化血红蛋白的葡糖基赖氨酸残基。为了简化样品制备,我们引入了三氯乙酸沉淀法以去除未反应的硼氢化钠,而不是使用透析或凝胶过滤。使用该程序,我们的放射免疫分析变得相对简单,批内和批间变异系数分别令人满意(分别为1.3 - 2.8%和1.9 - 5.4%)。将放射免疫分析方法与高效液相色谱法测定糖化血红蛋白进行了比较,高效液相色谱法是定量糖化血红蛋白最广泛使用的方法。为此,根据世界卫生组织标准,在正常糖耐量、糖耐量受损和糖尿病组中测定糖化血红蛋白。两种测定方法都能够区分正常组和糖尿病组。此外,虽然放射免疫分析方法测定糖化血红蛋白能够清楚地区分正常糖耐量组和糖耐量受损组,但高效液相色谱法测定糖化血红蛋白未能区分这两组。此外,20例糖耐量受损患者中有15例在放射免疫分析中超过正常上限范围(正常平均值 + 2标准差)。但所有20例糖耐量受损患者的糖化血红蛋白值均在正常上限范围内。这些结果表明,放射免疫分析测定糖化血红蛋白比高效液相色谱法测定糖化血红蛋白更敏感,因为它可以区分正常糖耐量组和糖耐量受损组。